Phase I study of mitonafide with a 3-day administration schedule: Early interruption due to severe central nervous system toxicity
1994; Springer Science+Business Media; Volume: 12; Issue: 4 Linguagem: Inglês
10.1007/bf00873041
ISSN1573-0646
AutoresEduardo Díaz‐Rubio, Miguel Martín, José Manuel López-Vega, Antonio Casado, Ana Benavides,
Tópico(s)Glioma Diagnosis and Treatment
Referência(s)